Independent Analyst update with details | ARWR Message Board Posts

Arrowhead Pharmaceuticals, Inc.

  ARWR website

ARWR   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board
Msg  10000 of 10041  at  5/31/2019 9:27:51 AM  by

Steve_382


 In response to msg 9999 by  Aspector
view thread

Re: Independent Analyst update with details

 There is a great deal of information compiled there and well worth reading. One comment I would make though, it seems a little disingenuous to refer to Alnylam's ESC platform drugs as retired or obsolete when many of them may result in approved drugs. The previous ARWR platform was retired due to safety issues and no drugs will be approved. Not exactly a fair comparison.
 
See the Platforms page for reference. 


     e-mail to a friend      printer-friendly     add to library      
| More
Recs: 2     Views: 221
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board

Replies
Msg # Subject Author Recs Date Posted
10001 Re: Independent Analyst update with details Aspector 6 5/31/2019 1:05:52 PM


About Us  �  Contact Us  �  Follow Us on Twitter  �  Members Directory  �  Help Center  �  Advertise
Not a member yet? What are you waiting for? Create Account
Want to contribute? Support InvestorVillage by donating
� 2003-2018 Investorvillage.com. All rights reserved. User Agreement
   
Financial Market Data provided by
.


Loading...